Targretin Capsule, Liquid Filled
NDC Package 0187-5526-75

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Targretin (bexarotene) capsules is bexarotene is used to treat skin problems from a certain type of cancer (cutaneous T-cell lymphoma-CTCL). This formulation utilizes a capsule, liquid filled delivery system. Marketed by Bausch Health Us, Llc, this product is identified by NDC 0187-5526 and is authorized under FDA application NDA021055.

Identification & Billing

NDC Package Code
0187-5526-75
Package Description
1 BOTTLE in 1 CARTON / 100 CAPSULE, LIQUID FILLED in 1 BOTTLE
Product Code
0187-5526
11-Digit Billing Format
00187552675
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Targretin
Non-Proprietary Name
Bexarotene
Substance Name
Bexarotene
Dosage Form
Capsule, Liquid Filled - A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
BEXAROTENE 75 mg/1
Pharmacologic Class
Usage Information
Bexarotene is used to treat skin problems from a certain type of cancer (cutaneous T-cell lymphoma-CTCL). It works by slowing or stopping the growth of these cancer cells. Bexarotene belongs to a class of drugs called retinoids (drugs related to vitamin A).

Regulatory & Marketing

Labeler Name
Bausch Health Us, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA021055
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-29-1999
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0187-5526-75 identifies a specific commercial package of 1 bottle in 1 carton / 100 capsule, liquid filled in 1 bottle of Targretin, a human prescription drug labeled by Bausch Health Us, Llc. This capsule, liquid filled is formulated for oral use and contains bexarotene as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch Health Us, Llc on December 29, 1999. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Bexarotene is used to treat skin problems from a certain type of cancer (cutaneous T-cell lymphoma-CTCL). It works by slowing or stopping the growth of these cancer cells. Bexarotene belongs to a class of drugs called retinoids (drugs related to vitamin A).

How is this Bausch Health Us, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00187552675. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0187-5526-75
11-Digit CMS (5-4-2)
00187-5526-75

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.